Also trades as: 9939.HK (HKSE) · $vol 0M
KNTPF OTC
Kintor Pharmaceutical Limited
1W: +0.0%
1M: +0.7%
3M: -29.4%
YTD: +11.8%
1Y: -6.7%
3Y: -75.8%
5Y: -80.4%
$0.24
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$199M
+48.6% ▲
Capital Expenditures
$2M
+38.3% ▲
5Y CAGR: +90.3%
Free Cash Flow
-$201M
+48.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$297M
+29.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$313K | -$516K | -$954K | -$1.1B | -$155M |
| Depreciation & Amort. | $6K | $10K | $18K | $19M | $18M |
| Stock-Based Comp. | $0 | $0 | $0 | $30K | -$9M |
| Change in Working Capital | -$13M | -$285M | -$198M | -$96M | -$51M |
| Other Non-Cash Items | $13M | $284M | $198M | $759M | -$1M |
| Operating Cash Flow | -$381K | -$1M | -$961K | -$388M | -$199M |
| — Investing Activities — | |||||
| Capital Expenditures | -$69K | -$76K | -$27K | -$3K | -$2M |
| Acquisitions (Net) | $345M | -$196M | -$19M | $0 | $0 |
| Investment Purchases | -$734M | -$515M | -$221M | -$137M | -$100K |
| Investment Sales | $389M | $711M | $337M | $136M | $10M |
| Other Investing | -$371K | $168K | -$98M | $4M | $12M |
| Investing Cash Flow | -$440K | $92K | $67K | $3M | $20M |
| — Financing Activities — | |||||
| Net Debt Issuance | $160M | -$64M | $122M | -$29M | -$115M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$1.8B | -$888M | -$820M | -$5M | -$5M |
| Financing Cash Flow | $2M | $857K | $816K | -$33M | -$120M |
| Net Change in Cash | $869K | -$138K | -$62K | -$420M | -$297M |
| Cash End of Period | $1M | $926K | $864K | $444M | $147M |
| Free Cash Flow | -$450K | -$1M | -$989K | -$390M | -$201M |